{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:27:44Z","timestamp":1789993664271,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.plefa.2007.08.006","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T18:00:10Z","timestamp":1191261610000},"page":"79-85","source":"Crossref","is-referenced-by-count":32,"title":["Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in Schizophrenia"],"prefix":"10.1016","volume":"77","author":[{"given":"Stefan","family":"Smesny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Stockebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe-Jens","family":"Gerhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Rosburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Blanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2007.08.006_bib1","series-title":"Nutrition and Biochemistry of Phospholipids","first-page":"50","article-title":"Altered prostaglandin mediated skin flush in schizophrenia\u2014implications for early psychosis interventions","author":"Smesny","year":"2003"},{"key":"10.1016\/j.plefa.2007.08.006_bib2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.plefa.2007.08.006_bib3","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","article-title":"Langerhans cells release prostaglandin D2 in response to nicotinic acid","volume":"126","author":"Maciejewski-Lenoir","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.plefa.2007.08.006_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2006.05.008","article-title":"The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target","volume":"27","author":"Offermanns","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.plefa.2007.08.006_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0278-5846(03)00152-0","article-title":"On the relationship between methylnicotinate-induced skin fush and fatty acid levels in acute psychosis","volume":"27","author":"Maclean","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2007.08.006_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","article-title":"The endophenotype concept in psychiatry: etymology and strategic intentions","volume":"160","author":"Gottesman","year":"2003","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical niacin skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale","volume":"37","author":"Smesny","year":"2003","journal-title":"J. Psychiat. Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"Smesny","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2007.08.006_bib10","series-title":"Strukturiertes Klinisches Interview f\u00fcr DSM-IV","author":"Wittchen","year":"1997"},{"key":"10.1016\/j.plefa.2007.08.006_bib11","series-title":"The Scale for the Assessment of Negative Symptoms","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.plefa.2007.08.006_bib12","series-title":"The Scale for the Assessment of Positive Symptoms","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.plefa.2007.08.006_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1515\/bmte.2001.46.10.280","article-title":"Quantitative assessment of niacin induced skin flusing using optical reflection spectroscopy\u2014method and clinical application","volume":"46","author":"Smesny","year":"2001","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.plefa.2007.08.006_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0447.1986.tb10594.x","article-title":"Clinical methods in psychiatric genetics, I: robustness of genetic marker investigative strategies","volume":"74","author":"Gershon","year":"1986","journal-title":"Acta Psychiat. Scand."},{"key":"10.1016\/j.plefa.2007.08.006_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","article-title":"The niacin skin flush test in schizophrenia: a replication study","volume":"55","author":"Puri","year":"2001","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.plefa.2007.08.006_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"Puri","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0924-977X(03)00145-7","article-title":"Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry","volume":"14","author":"Ross","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2007.08.006_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0006-3223(91)90202-W","article-title":"Niacin test in schizophrenia and affective illness","volume":"29","author":"Rybakowski","year":"1991","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib20","first-page":"163","article-title":"Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin","volume":"43","author":"Shah","year":"2000","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia: a preliminary report","volume":"29","author":"Ward","year":"1998","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/schbul\/sbl038","article-title":"Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives","volume":"33","author":"Lin","year":"2007","journal-title":"Schizophrenia Bull."},{"key":"10.1016\/j.plefa.2007.08.006_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-9964(99)00031-6","article-title":"Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics","volume":"40","author":"Waldo","year":"1999","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib25","article-title":"Niacin flush skin test in parent\u2013offspring trios affected with schizophrenia","volume":"114","author":"Nikolov","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.plefa.2007.08.006_bib26","first-page":"314","article-title":"The niacin skin flush test: first-degree relatives show responses intermediate between patients and controls","volume":"36","author":"Shah","year":"1999","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/plef.2000.0192","article-title":"Could oxidative stress be a factor in neurodevelopmental disorders?","volume":"63","author":"Ross","year":"2000","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2007.08.006_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.plefa.2007.08.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophrenia Bull."},{"key":"10.1016\/j.plefa.2007.08.006_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-9964(03)00011-2","article-title":"A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress","volume":"65","author":"Marchbanks","year":"2003","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.plefa.2007.08.006_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.plefa.2007.08.006_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-004-0477-2","article-title":"Immunological and infectious aspects of schizophrenia","volume":"254","author":"Muller","year":"2004","journal-title":"Eur. Arch. Psychiat. Clin. Neurosci."},{"key":"10.1016\/j.plefa.2007.08.006_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"Horrobin","year":"1977","journal-title":"Lancet"},{"issue":"Suppl. 4 IV","key":"10.1016\/j.plefa.2007.08.006_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/PL00014187","article-title":"The role of immune function in schizophrenia: an overview","volume":"249","author":"M\u00fcller","year":"1999","journal-title":"Eur. Arch. Psychiat. Clin. Neurosci."},{"key":"10.1016\/j.plefa.2007.08.006_bib37","doi-asserted-by":"crossref","unstructured":"Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. Neuropsychopharmacology 2007, in press.","DOI":"10.1038\/sj.npp.1301343"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327807001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327807001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T08:59:25Z","timestamp":1684054765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327807001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0952327807001044"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2007.08.006","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}